RARB and fatty liver disease: In both models, treatment of WT mice with a selective RARβ2 agonist (with RARβ2 being the most abundant RARβ isotype), AC261066, limited hepatic steatosis, cellular stress, and inflammation compared to mice not given AC261066 [16,17,18,19].